0
     

Report Added
Report already added
Radiopharmaceuticals Market in India - Manufacturing and Consumption, Outlook and Forecast 2020-2026

Radiopharmaceuticals Market in India - Manufacturing and Consumption, Outlook and Forecast 2020-2026

Radiopharmaceuticals are radioactive compounds administered to the patient, and monitored via specific imaging devices, for diagnosis and therapeutic purposes. It is composed of a radioisotope bond to an organic molecule. The organic molecule conveys the radioisotope to specific organs, tissues or cells. The radioisotope is selected for its properties. Radiopharmaceuticals are used in the field of nuclear medicine as radioactive tracers in medical imaging and in therapy for many diseases (for example, brachytherapy). Many radiopharmaceuticals use technetium-99m (Tc-99m) which has many useful properties as a gamma-emitting tracer nuclide._x000D_
_x000D_
This report contains market size and forecasts of Radiopharmaceuticals in India, including the following market information:_x000D_
India Radiopharmaceuticals Market Revenue, 2015-2020, 2021-2026, ($ millions)_x000D_
India Radiopharmaceuticals Market Consumption, 2015-2020, 2021-2026, (K Dose)_x000D_
India Radiopharmaceuticals Production Capacity, 2015-2020, 2021-2026, (K Dose)_x000D_
Top Five Competitors in India Radiopharmaceuticals Market 2019 (%)_x000D_
The global Radiopharmaceuticals market was valued at 5929.1 million in 2019 and is projected to reach US$ 7964.2 million by 2026, at a CAGR of 7.7% during the forecast period. While the Radiopharmaceuticals market size in India was US$ XX million in 2019, and it is expected to reach US$ XX million by the end of 2026, with a CAGR of XX% during 2020-2026._x000D_
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Radiopharmaceuticals manufacturers, suppliers, distributors and industry experts on the impacts of the COVID-19 pandemic on businesses, with top challenges including ingredients and raw material delays, component and packaging shortages, reduced/cancelled orders from clients and consumers, and closures of production lines in some impacted areas._x000D_
This report also analyses and evaluates the COVID-19 impact on Radiopharmaceuticals production and consumption in India_x000D_
Total Market by Segment:_x000D_
India Radiopharmaceuticals Market, By Type, 2015-2020, 2021-2026 ($ millions) & (K Dose)_x000D_
India Radiopharmaceuticals Market Segment Percentages, By Type, 2019 (%)_x000D_
Diagnostic Radioisotopes_x000D_
Therapeutic Radioisotopes_x000D_
_x000D_
India Radiopharmaceuticals Market, By Application, 2015-2020, 2021-2026 ($ millions) & (K Dose)_x000D_
India Radiopharmaceuticals Market Segment Percentages, By Application, 2019 (%)_x000D_
Oncology_x000D_
Cardiology_x000D_
Other_x000D_
_x000D_
Competitor Analysis_x000D_
The report also provides analysis of leading market participants including:_x000D_
Total Radiopharmaceuticals Market Competitors Revenues in India, by Players 2015-2020 (Estimated), ($ millions)_x000D_
Total Radiopharmaceuticals Market Competitors Revenues Share in India, by Players 2019 (%)_x000D_
Total India Radiopharmaceuticals Market Competitors Sales, by Players 2015-2020 (Estimated), (K Dose)_x000D_
Total India Radiopharmaceuticals Market Competitors Sales Market Share by Players 2019 ($ millions)_x000D_
Further, the report presents profiles of competitors in the market, including the following:_x000D_
Bracco Imaging_x000D_
Bayer_x000D_
Mallinckrodt_x000D_
Nordion_x000D_
Triad Isotopes_x000D_
Lantheus_x000D_
IBA Group_x000D_
GE Healthcare_x000D_
China Isotope & Radiation_x000D_
Jubilant Pharma_x000D_
Eli Lilly_x000D_
Advanced Accelerator Applications_x000D_
SIEMENS_x000D_
Dongcheng_x000D_
1 Introduction to Research & Analysis Reports_x000D_
1.1 Radiopharmaceuticals Market Definition_x000D_
1.2 Market Segments_x000D_
1.2.1 Segment by Type_x000D_
1.2.2 Segment by Application_x000D_
1.3 India Radiopharmaceuticals Market Overview_x000D_
1.4 Features & Benefits of This Report_x000D_
1.5 Methodology & Sources of Information_x000D_
1.5.1 Research Methodology_x000D_
1.5.2 Research Process_x000D_
1.5.3 Base Year_x000D_
1.5.4 Report Assumptions & Caveats_x000D_
_x000D_
2 COVID-19 Impact: India Radiopharmaceuticals Overall Market Size_x000D_
2.1 India Radiopharmaceuticals Market Size: 2020 VS 2026_x000D_
2.2 India Radiopharmaceuticals Revenue, Prospects & Forecasts: 2015-2026_x000D_
2.3 India Radiopharmaceuticals Sales (Consumption): 2015-2026_x000D_
_x000D_
3 Company Landscape_x000D_
3.1 Top Radiopharmaceuticals Players in India (including Foreign and Local Companies)_x000D_
3.2 Top India Radiopharmaceuticals Companies Ranked by Revenue_x000D_
3.3 India Radiopharmaceuticals Revenue by Companies (including Foreign and Local Companies)_x000D_
3.4 India Radiopharmaceuticals Sales by Companies (including Foreign and Local Companies)_x000D_
3.5 India Radiopharmaceuticals Price by Manufacturer (2015-2020)_x000D_
3.6 Top 3 and Top 5 Radiopharmaceuticals Companies in India, by Revenue in 2019_x000D_
3.7 India Manufacturers Radiopharmaceuticals Product Type_x000D_
3.8 Tier 1, Tier 2 and Tier 3 Radiopharmaceuticals Players in India_x000D_
3.8.1 List of India Tier 1 Radiopharmaceuticals Companies_x000D_
3.8.2 List of India Tier 2 and Tier 3 Radiopharmaceuticals Companies_x000D_
_x000D_
4 Sights by Product_x000D_
4.1 Overview_x000D_
4.1.1 By Type - India Radiopharmaceuticals Market Size Markets, 2020 & 2026_x000D_
4.1.2 Diagnostic Radioisotopes_x000D_
4.1.3 Therapeutic Radioisotopes_x000D_
4.2 By Type - India Radiopharmaceuticals Revenue & Forecasts_x000D_
4.2.1 By Type - India Radiopharmaceuticals Revenue, 2015-2020_x000D_
4.2.2 By Type - India Radiopharmaceuticals Revenue, 2021-2026_x000D_
4.2.3 By Type - India Radiopharmaceuticals Revenue Market Share, 2015-2026_x000D_
4.3 By Type - India Radiopharmaceuticals Sales & Forecasts_x000D_
4.3.1 By Type - India Radiopharmaceuticals Sales, 2015-2020_x000D_
4.3.2 By Type - India Radiopharmaceuticals Sales, 2021-2026_x000D_
4.3.3 By Type - India Radiopharmaceuticals Sales Market Share, 2015-2026_x000D_
4.4 By Type - India Radiopharmaceuticals Price (Manufacturers Selling Prices), 2015-2026_x000D_
5 Sights by Application_x000D_
5.1 Overview_x000D_
5.1.1 By Application - India Radiopharmaceuticals Market Size, 2020 & 2026_x000D_
5.1.2 Oncology_x000D_
5.1.3 Cardiology_x000D_
5.1.4 Other_x000D_
5.2 By Application - India Radiopharmaceuticals Revenue & Forecasts_x000D_
5.2.1 By Application - India Radiopharmaceuticals Revenue, 2015-2020_x000D_
5.2.2 By Application - India Radiopharmaceuticals Revenue, 2021-2026_x000D_
5.2.3 By Application - India Radiopharmaceuticals Revenue Market Share, 2015-2026_x000D_
5.3 By Application - India Radiopharmaceuticals Sales & Forecasts_x000D_
5.3.1 By Application - India Radiopharmaceuticals Sales, 2015-2020_x000D_
5.3.2 By Application - India Radiopharmaceuticals Sales, 2021-2026_x000D_
5.3.3 By Application - India Radiopharmaceuticals Sales Market Share, 2015-2026_x000D_
5.4 By Application - India Radiopharmaceuticals Price (Manufacturers Selling Prices), 2015-2026_x000D_
6 Manufacturers & Brands Profiles_x000D_
6.1 Bracco Imaging_x000D_
6.1.1 Bracco Imaging Corporate Summary_x000D_
6.1.2 Bracco Imaging Business Overview_x000D_
6.1.3 Bracco Imaging Radiopharmaceuticals Major Product Offerings_x000D_
6.1.4 Bracco Imaging Sales and Revenue in India (2015-2020)_x000D_
6.1.5 Bracco Imaging Key News_x000D_
6.2 Bayer_x000D_
6.2.1 Bayer Corporate Summary_x000D_
6.2.2 Bayer Business Overview_x000D_
6.2.3 Bayer Radiopharmaceuticals Major Product Offerings_x000D_
6.2.4 Bayer Sales and Revenue in India (2015-2020)_x000D_
6.2.5 Bayer Key News_x000D_
6.3 Mallinckrodt_x000D_
6.3.1 Mallinckrodt Corporate Summary_x000D_
6.3.2 Mallinckrodt Business Overview_x000D_
6.3.3 Mallinckrodt Radiopharmaceuticals Major Product Offerings_x000D_
6.3.4 Mallinckrodt Sales and Revenue in India (2015-2020)_x000D_
6.3.5 Mallinckrodt Key News_x000D_
6.4 Nordion_x000D_
6.4.1 Nordion Corporate Summary_x000D_
6.4.2 Nordion Business Overview_x000D_
6.4.3 Nordion Radiopharmaceuticals Major Product Offerings_x000D_
6.4.4 Nordion Sales and Revenue in India (2015-2020)_x000D_
6.4.5 Nordion Key News_x000D_
6.5 Triad Isotopes_x000D_
6.5.1 Triad Isotopes Corporate Summary_x000D_
6.5.2 Triad Isotopes Business Overview_x000D_
6.5.3 Triad Isotopes Radiopharmaceuticals Major Product Offerings_x000D_
6.5.4 Triad Isotopes Sales and Revenue in India (2015-2020)_x000D_
6.5.5 Triad Isotopes Key News_x000D_
6.6 Lantheus_x000D_
6.6.1 Lantheus Corporate Summary_x000D_
6.6.2 Lantheus Business Overview_x000D_
6.6.3 Lantheus Radiopharmaceuticals Major Product Offerings_x000D_
6.6.4 Lantheus Sales and Revenue in India (2015-2020)_x000D_
6.6.5 Lantheus Key News_x000D_
6.7 IBA Group_x000D_
6.6.1 IBA Group Corporate Summary_x000D_
6.6.2 IBA Group Business Overview_x000D_
6.6.3 IBA Group Radiopharmaceuticals Major Product Offerings_x000D_
6.4.4 IBA Group Sales and Revenue in India (2015-2020)_x000D_
6.7.5 IBA Group Key News_x000D_
6.8 GE Healthcare_x000D_
6.8.1 GE Healthcare Corporate Summary_x000D_
6.8.2 GE Healthcare Business Overview_x000D_
6.8.3 GE Healthcare Radiopharmaceuticals Major Product Offerings_x000D_
6.8.4 GE Healthcare Sales and Revenue in India (2015-2020)_x000D_
6.8.5 GE Healthcare Key News_x000D_
6.9 China Isotope & Radiation_x000D_
6.9.1 China Isotope & Radiation Corporate Summary_x000D_
6.9.2 China Isotope & Radiation Business Overview_x000D_
6.9.3 China Isotope & Radiation Radiopharmaceuticals Major Product Offerings_x000D_
6.9.4 China Isotope & Radiation Sales and Revenue in India (2015-2020)_x000D_
6.9.5 China Isotope & Radiation Key News_x000D_
6.10 Jubilant Pharma_x000D_
6.10.1 Jubilant Pharma Corporate Summary_x000D_
6.10.2 Jubilant Pharma Business Overview_x000D_
6.10.3 Jubilant Pharma Radiopharmaceuticals Major Product Offerings_x000D_
6.10.4 Jubilant Pharma Sales and Revenue in India (2015-2020)_x000D_
6.10.5 Jubilant Pharma Key News_x000D_
6.11 Eli Lilly_x000D_
6.11.1 Eli Lilly Corporate Summary_x000D_
6.11.2 Eli Lilly Radiopharmaceuticals Business Overview_x000D_
6.11.3 Eli Lilly Radiopharmaceuticals Major Product Offerings_x000D_
6.11.4 Eli Lilly Sales and Revenue in India (2015-2020)_x000D_
6.11.5 Eli Lilly Key News_x000D_
6.12 Advanced Accelerator Applications_x000D_
6.12.1 Advanced Accelerator Applications Corporate Summary_x000D_
6.12.2 Advanced Accelerator Applications Radiopharmaceuticals Business Overview_x000D_
6.12.3 Advanced Accelerator Applications Radiopharmaceuticals Major Product Offerings_x000D_
6.12.4 Advanced Accelerator Applications Sales and Revenue in India (2015-2020)_x000D_
6.12.5 Advanced Accelerator Applications Key News_x000D_
6.13 SIEMENS_x000D_
6.13.1 SIEMENS Corporate Summary_x000D_
6.13.2 SIEMENS Radiopharmaceuticals Business Overview_x000D_
6.13.3 SIEMENS Radiopharmaceuticals Major Product Offerings_x000D_
6.13.4 SIEMENS Sales and Revenue in India (2015-2020)_x000D_
6.13.5 SIEMENS Key News_x000D_
6.14 Dongcheng_x000D_
6.14.1 Dongcheng Corporate Summary_x000D_
6.14.2 Dongcheng Radiopharmaceuticals Business Overview_x000D_
6.14.3 Dongcheng Radiopharmaceuticals Major Product Offerings_x000D_
6.14.4 Dongcheng Sales and Revenue in India (2015-2020)_x000D_
6.14.5 Dongcheng Key News_x000D_
6.15 Navidea_x000D_
6.15.1 Navidea Corporate Summary_x000D_
6.15.2 Navidea Radiopharmaceuticals Business Overview_x000D_
6.15.3 Navidea Radiopharmaceuticals Major Product Offerings_x000D_
6.15.4 Navidea Sales and Revenue in India (2015-2020)_x000D_
6.15.5 Navidea Key News_x000D_
_x000D_
7 Radiopharmaceuticals Production Capacity, Export and Import Analysis_x000D_
7.1 Radiopharmaceuticals Production Capacity and Value in India, Situation Analysis and Prediction, 2015-2026_x000D_
7.1.1 India Radiopharmaceuticals Production Capacity, 2015-2026_x000D_
7.1.2 India Radiopharmaceuticals Production 2015-2026_x000D_
7.1.3 India Radiopharmaceuticals Production Value 2015-2026_x000D_
7.2 Key Local Radiopharmaceuticals Manufacturers in India_x000D_
7.2.1 India Key Local Radiopharmaceuticals Manufacturers Production Capacity_x000D_
7.2.2 India Key Local Radiopharmaceuticals Manufacturers Production_x000D_
7.2.3 India Key Local Radiopharmaceuticals Manufacturers Production Value_x000D_
7.2.4 The Proportion of Radiopharmaceuticals Production Sold in India and Sold Other Than India by Manufacturers_x000D_
7.3 Radiopharmaceuticals Export and Import in India_x000D_
7.3.1 India Radiopharmaceuticals Export Market_x000D_
7.3.2 India Radiopharmaceuticals Source of Imports_x000D_
_x000D_
8 COVID-19 Impact: Key Market Trends, Opportunity, Drivers and Restraints_x000D_
8.1 PESTLE Analysis for India Radiopharmaceuticals Market_x000D_
8.2 Market Opportunities & Trends_x000D_
8.3 Market Drivers_x000D_
8.4 Market Restraints_x000D_
_x000D_
9 COVID-19 Impact on Radiopharmaceuticals Supply Chain Analysis_x000D_
9.1 Supply Chain Analysis_x000D_
9.2 Upstream Market Analysis_x000D_
9.3 Downstream and Clients Market Analysis_x000D_
9.4 Marketing Channels Analysis_x000D_
9.4.1 Marketing Channels_x000D_
9.4.2 Radiopharmaceuticals Distributors and Sales Agents in India_x000D_
_x000D_
10 Conclusion_x000D_
_x000D_
11 Appendix_x000D_
11.1 Note_x000D_
11.2 Examples of Clients_x000D_
11.3 Disclaimer_x000D_
List of Tables_x000D_
Table 1. Key Players of Radiopharmaceuticals in India_x000D_
Table 2. Top Players in India, Ranking by Revenue (2019)_x000D_
Table 3. India Radiopharmaceuticals Revenue by Companies, (US$, Mn), 2015-2020_x000D_
Table 4. India Radiopharmaceuticals Revenue Share by Companies, 2015-2020_x000D_
Table 5. India Radiopharmaceuticals Sales by Companies, (K Dose), 2015-2020_x000D_
Table 6. India Radiopharmaceuticals Sales Share by Companies, 2015-2020_x000D_
Table 7. Key Manufacturers Radiopharmaceuticals Price (2015-2020) (USD/Dose)_x000D_
Table 8. India Manufacturers Radiopharmaceuticals Product Type_x000D_
Table 9. List of India Tier 1 Radiopharmaceuticals Companies, Revenue (US$, Mn) in 2019 and Market Share_x000D_
Table 10. List of India Tier 2 and Tier 3 Radiopharmaceuticals Companies, Revenue (US$, Mn) in 2019 and Market Share_x000D_
Table 11. By Type - Radiopharmaceuticals Revenue in India (US$, Mn), 2015-2020_x000D_
Table 12. By Type - Radiopharmaceuticals Revenue in India (US$, Mn), 2021-2026_x000D_
Table 13. By Type - Radiopharmaceuticals Sales in India (K Dose), 2015-2020_x000D_
Table 14. By Type - Radiopharmaceuticals Sales in India (K Dose), 2021-2026_x000D_
Table 15. By Application - Radiopharmaceuticals Revenue in India, (US$, Mn), 2015-2020_x000D_
Table 16. By Application - Radiopharmaceuticals Revenue in India, (US$, Mn), 2021-2026_x000D_
Table 17. By Application - Radiopharmaceuticals Sales in India, (K Dose), 2015-2020_x000D_
Table 18. By Application - Radiopharmaceuticals Sales in India, (K Dose), 2021-2026_x000D_
Table 19. Bracco Imaging Corporate Summary_x000D_
Table 20. Bracco Imaging Radiopharmaceuticals Product Offerings_x000D_
Table 21. Bracco Imaging Radiopharmaceuticals Sales (K Dose), Revenue (US$, Mn) and Average Price (USD/Dose) (2015-2020)_x000D_
Table 22. Bayer Corporate Summary_x000D_
Table 23. Bayer Radiopharmaceuticals Product Offerings_x000D_
Table 24. Bayer Radiopharmaceuticals Sales (K Dose), Revenue (US$, Mn) and Average Price (USD/Dose) (2015-2020)_x000D_
Table 25. Mallinckrodt Corporate Summary_x000D_
Table 26. Mallinckrodt Radiopharmaceuticals Product Offerings_x000D_
Table 27. Mallinckrodt Radiopharmaceuticals Sales (K Dose), Revenue (US$, Mn) and Average Price (USD/Dose) (2015-2020)_x000D_
Table 28. Nordion Corporate Summary_x000D_
Table 29. Nordion Radiopharmaceuticals Product Offerings_x000D_
Table 30. Nordion Radiopharmaceuticals Sales (K Dose), Revenue (US$, Mn) and Average Price (USD/Dose) (2015-2020)_x000D_
Table 31. Triad Isotopes Corporate Summary_x000D_
Table 32. Triad Isotopes Radiopharmaceuticals Product Offerings_x000D_
Table 33. Triad Isotopes Radiopharmaceuticals Sales (K Dose), Revenue (US$, Mn) and Average Price (USD/Dose) (2015-2020)_x000D_
Table 34. Lantheus Corporate Summary_x000D_
Table 35. Lantheus Radiopharmaceuticals Product Offerings_x000D_
Table 36. Lantheus Radiopharmaceuticals Sales (K Dose), Revenue (US$, Mn) and Average Price (USD/Dose) (2015-2020)_x000D_
Table 37. IBA Group Corporate Summary_x000D_
Table 38. IBA Group Radiopharmaceuticals Product Offerings_x000D_
Table 39. IBA Group Radiopharmaceuticals Sales (K Dose), Revenue (US$, Mn) and Average Price (USD/Dose) (2015-2020)_x000D_
Table 40. GE Healthcare Corporate Summary_x000D_
Table 41. GE Healthcare Radiopharmaceuticals Product Offerings_x000D_
Table 42. GE Healthcare Radiopharmaceuticals Sales (K Dose), Revenue (US$, Mn) and Average Price (USD/Dose) (2015-2020)_x000D_
Table 43. China Isotope & Radiation Corporate Summary_x000D_
Table 44. China Isotope & Radiation Radiopharmaceuticals Product Offerings_x000D_
Table 45. China Isotope & Radiation Radiopharmaceuticals Sales (K Dose), Revenue (US$, Mn) and Average Price (USD/Dose) (2015-2020)_x000D_
Table 46. Jubilant Pharma Corporate Summary_x000D_
Table 47. Jubilant Pharma Radiopharmaceuticals Product Offerings_x000D_
Table 48. Jubilant Pharma Radiopharmaceuticals Sales (K Dose), Revenue (US$, Mn) and Average Price (USD/Dose) (2015-2020)_x000D_
Table 49. Eli Lilly Corporate Summary_x000D_
Table 50. Eli Lilly Radiopharmaceuticals Product Offerings_x000D_
Table 51. Eli Lilly Radiopharmaceuticals Sales (K Dose), Revenue (US$, Mn) and Average Price (USD/Dose) (2015-2020)_x000D_
Table 52. Advanced Accelerator Applications Corporate Summary_x000D_
Table 53. Advanced Accelerator Applications Radiopharmaceuticals Product Offerings_x000D_
Table 54. Advanced Accelerator Applications Radiopharmaceuticals Sales (K Dose), Revenue (US$, Mn) and Average Price (USD/Dose) (2015-2020)_x000D_
Table 55. SIEMENS Corporate Summary_x000D_
Table 56. SIEMENS Radiopharmaceuticals Product Offerings_x000D_
Table 57. SIEMENS Radiopharmaceuticals Sales (K Dose), Revenue (US$, Mn) and Average Price (USD/Dose) (2015-2020)_x000D_
Table 58. Dongcheng Corporate Summary_x000D_
Table 59. Dongcheng Radiopharmaceuticals Product Offerings_x000D_
Table 60. Dongcheng Radiopharmaceuticals Sales (K Dose), Revenue (US$, Mn) and Average Price (USD/Dose) (2015-2020)_x000D_
Table 61. Navidea Corporate Summary_x000D_
Table 62. Navidea Radiopharmaceuticals Product Offerings_x000D_
Table 63. Navidea Radiopharmaceuticals Sales (K Dose), Revenue (US$, Mn) and Average Price (USD/Dose) (2015-2020)_x000D_
Table 64. Radiopharmaceuticals Production Capacity (K Dose) of Local Manufacturers in India, 2015-2020_x000D_
Table 65. Radiopharmaceuticals Production (K Dose) of Local Manufacturers in India, 2015-2020_x000D_
Table 66. India Radiopharmaceuticals Production Market Share of Local Manufacturers, 2015-2020_x000D_
Table 67. Radiopharmaceuticals Production Value (US$, Mn) of Local Manufacturers in India, 2015-2020_x000D_
Table 68. India Radiopharmaceuticals Production Value Market Share of Local Manufacturers, 2015-2020_x000D_
Table 69. The Percentage of Radiopharmaceuticals Production Sold in India and Sold Other Than India by Manufacturers_x000D_
Table 70. The Percentage of Radiopharmaceuticals Production Sold in India and Sold Other Than India by Manufacturers_x000D_
Table 71. Dangeguojia Radiopharmaceuticals Sales (Consumption), Production, Export and Import, 2015-2020_x000D_
Table 72. Raw Materials and Suppliers_x000D_
Table 73. Radiopharmaceuticals Downstream Clients in India_x000D_
Table 74. Radiopharmaceuticals Distributors and Sales Agents in India_x000D_
List of Figures_x000D_
Figure 1. Radiopharmaceuticals Segment by Type_x000D_
Figure 2. Radiopharmaceuticals Segment by Application_x000D_
Figure 3. Dangeguojia Radiopharmaceuticals Market Overview: 2020_x000D_
Figure 4. Key Caveats_x000D_
Figure 5. Radiopharmaceuticals Market Size in India, (US$, Mn) & (K Dose): 2020 VS 2026_x000D_
Figure 6. India Radiopharmaceuticals Revenue, 2015-2026 (US$, Mn)_x000D_
Figure 7. Radiopharmaceuticals Sales in India: 2015-2026 (K Dose)_x000D_
Figure 8. The Top 3 and 5 Players Market Share by Radiopharmaceuticals Revenue in 2019_x000D_
Figure 9. By Type - India Radiopharmaceuticals Incremental Growth, (US$, Mn), 2015-2026_x000D_
Figure 10. By Type - India Radiopharmaceuticals Market Share, 2015-2020_x000D_
Figure 11. By Type - India Radiopharmaceuticals Market Share, 2020-2026_x000D_
Figure 12. By Type - India Radiopharmaceuticals Price (USD/Dose), 2015-2026_x000D_
Figure 13. By Application - Radiopharmaceuticals Revenue in India (US$, Mn), 2020 & 2026_x000D_
Figure 14. By Application - India Radiopharmaceuticals Market Share, 2015-2020_x000D_
Figure 15. By Application - India Radiopharmaceuticals Market Share, 2020-2026_x000D_
Figure 16. By Application -India Radiopharmaceuticals Price (USD/Dose), 2015-2026_x000D_
Figure 17. India Radiopharmaceuticals Production Capacity (K Dose), 2015-2026_x000D_
Figure 18. India Radiopharmaceuticals Actual Output (K Dose), 2015-2026_x000D_
Figure 19. India Radiopharmaceuticals Production Value (US$, Mn), 2015-2026_x000D_
Figure 20. The Percentage of India Radiopharmaceuticals Export Destination, 2019_x000D_
Figure 21. The Source of Imports of India Radiopharmaceuticals, 2019_x000D_
Figure 22. PEST Analysis for India Radiopharmaceuticals Market in 2020_x000D_
Figure 23. Radiopharmaceuticals Market Opportunities & Trends in India_x000D_
Figure 24. Radiopharmaceuticals Market Drivers in India_x000D_
Figure 25. Radiopharmaceuticals Market Restraints in India_x000D_
Figure 26. Radiopharmaceuticals Industry Value Chain_x000D_

Kindly Fill The Form Below

Report Title: Radiopharmaceuticals Market in India - Manufacturing and Consumption, Outlook and Forecast 2020-2026


Valid Invalid number

SELECT A FORMAT

ADD TO CART BUY NOW